MCRB compared with SANA: revenue, margins and what each company keeps, and the suppliers and customers both name

MCRBSeres Therapeutics, Inc.

Mkt capRevenueRevenue

SANASana Biotechnology, Inc.

Mkt capRevenueRevenue

Compare

MCRBSeres Therapeutics, Inc.

SANASana Biotechnology, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MCRB 11

—Bactheraunlistedsupplier

—CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator)unlistedsupplier

—Crohn's and Colitis Foundationunlistedsupplier

—Columbia Universityunlistedsupplier

7 more · MCRB chain ›

Shared 0

No shared counterparties.

Only SANA 11

BEAMBeam Therapeutics, Inc. (Beam)supplier

—Flagship Pioneering Innovations V, Inc. (Flagship)unlistedsupplier

—FUJIFILM Cellular Dynamics, Inc. (FCDI)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

La Societe Pulsalys (Pulsalys)

unlistedsupplier

7 more · SANA chain ›

MCRBSeres Therapeutics, Inc.

2.17▲+4.02%

Mkt cap$21.3MRevenue$593,000Q3 FY26

SANASana Biotechnology, Inc.

2.34▼−0.21%

Regular sessionNov 6 '26

Mkt cap$701.1MRevenue—

Compare

Regular sessionNov 6 '26

MCRBSeres Therapeutics, Inc.

SANASana Biotechnology, Inc.

2.17▲+4.02%

Price

2.34▼−0.21%

$21.3M

Mkt cap

$701.1M

Q3 FY26$593,000

Revenue

—

MCRB2.17▲+4.02%vsSANA2.34▼−0.21%Regular sessionNov 6 '26